Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

Improving alcohol and substance use care during the reproductive years

Official title: Improving Alcohol and Substance Use Care Access, Outcomes, and Equity During the Reproductive Years: A Type 1 Hybrid Trial in Family Planning Clinics

Run by Emory University · NCT05910580 · Data updated 2026-11-12

This project will test whether offering SBIRT (screening, brief intervention, and referral to treatment) in sexual and reproductive health clinics helps adults who screen positive for risky alcohol or drug use reduce substance use and improve mental, reproductive, and overall health.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorEmory University
Academic / other
Locations4 sites (Boston, Massachusetts and 3 other locations)
StatusRecruiting
StartedJuly 3, 2025
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedJune 15, 2026
Trial IDNCT05910580 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older who live in the U.S., can read English or Spanish, have internet access, are receiving care at participating sexual and reproductive health clinics in Massachusetts, and screen positive for risky alcohol or substance use are ideal candidates.

Probably not a fit

People without risky substance use, those needing more intensive addiction treatment than SBIRT provides, those who cannot read English or Spanish, lack internet access, or cannot attend participating clinics are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project compares SBIRT delivered in-person or by telemedicine to usual care for adults who screen positive for risky alcohol or substance use at sexual and reproductive health clinics. Participants are recruited at three Planned Parenthood–affiliated centers in Massachusetts, complete baseline, 30-day, and 3-month surveys, and receive either SBIRT (in-person or telehealth) or usual care. Outcomes include substance use, sexual and reproductive health, mental and physical health, quality of life, and wellbeing, with subgroup analyses by age, gender, ethnicity, socioeconomic status, and urbanicity. The trial also examines differences in outcomes by delivery mode and evaluates implementation in community-based family planning settings.

Why it matters

Potential benefit: If successful, this approach could expand access to brief substance-use care in family planning clinics and reduce substance use and related reproductive and mental health harms among reproductive-aged adults.

How similar studies have gone: SBIRT has shown benefit for reducing risky alcohol use in some primary care and emergency settings, but evidence for drug use outcomes and for implementation in sexual and reproductive health clinics is limited, making this application relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Over the age of 18 years
* U.S. residing
* Have internet access (own a computer or smart phone)
* Screen positive to one or more risky alcohol and substance use behaviors as determined by our standardized abbreviated instruments

Exclusion Criteria:

* Not capable of communicating (reading, speaking, writing) in English or Spanish

Where it's running

  • Greater Boston Health Center
    Boston, Massachusetts, United States
    Recruiting
  • Metro West Health Center
    Marlborough, Massachusetts, United States
    Recruiting
  • Western Massachusetts Health Center
    Springfield, Massachusetts, United States
    Recruiting
  • Central Massachusetts Health Center
    Worcester, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.